Implantable Loop Recorders Market Size to grow by USD 532.7 million between 2024-2028
According to a research report “ Implantable Loop Recorders Market” by Application (Cardiac arrhythmia, Atrial fibrillation) Type (Automatic, Manual) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 532.7 million, at a CAGR of 6.78% during the forecast period. The implantable loop recorder market is experiencing significant growth due to the increasing prevalence of cardiac conditions linked to irregular heart rhythms and structural heart diseases. According to the Centers for Disease Control and Prevention (CDC), approximately 209,000 people undergo in-hospital cardiac arrest in the US annually. Structural heart diseases, such as cardiomyopathy, can lead to arrhythmia by inducing ventricular fibrillation and ventricular tachycardia. The National Health Service (NHS) reports that hypertrophic cardiomyopathy, a genetically inherited cardiac disease, affects 1 in every 500 individuals in the UK. These conditions underscore the importance of advanced arrhythmia monitoring devices to improve patient outcomes and reduce the risk of sudden cardiac arrest..
Browse market data tables, figures, and in-depth TOC on “Implantable Loop Recorders Market” by Application (Cardiac arrhythmia, Atrial fibrillation) Type (Automatic, Manual) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By Application, the Cardiac arrhythmia segment is projected to dominate the market size in 2024
The Implantable Loop Recorder (ILR) market represents a significant growth opportunity for healthcare technology companies. These devices, which continuously monitor cardiac rhythm, offer improved diagnostic accuracy for arrhythmia detection. With increasing prevalence of cardiac conditions and rising demand for minimally invasive diagnostic tools, the market is poised for robust expansion. Manufacturers are investing in research and development to enhance the features and functionality of ILRs, ensuring they remain at the forefront of cardiac care technology.
By Type, Automatic segment is expected to hold the largest market size for the year 2024
The implantable loop recorder is a sophisticated medical device that continuously monitors a patient's heart rhythm for an extended period. The implantation process involves scheduling a remote monitoring appointment every 31 days. During this appointment, the device automatically transmits the recorded data to the healthcare provider's office, eliminating the need for patient intervention. In case of an abnormal rhythm detection within the 31-day interval, the healthcare provider receives an alert and contacts the patient for further evaluation and potential adjustments. Patients are also advised to send in remote readings and contact the office if they experience any symptoms. Upon implantation, the patient receives a remote monitoring box, which can be obtained either at the time of the procedure or through mail from the device manufacturer.
North America is forecasted to hold the largest market size by region in 2024
The Implantable Loop Recorder (ILR) market signifies a significant growth opportunity for healthcare technology providers. These devices, which continuously monitor cardiac rhythm, offer invaluable diagnostic insights for arrhythmia detection and management. Market expansion is driven by increasing prevalence of cardiac disorders, technological advancements, and growing demand for minimally invasive monitoring solutions. Key players in this sector include Medtronic, Boston Scientific, and Abbott Laboratories.
The Implantable Loop Recorders Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
The Implantable Loop Recorder (ILR) market is a significant segment of the medical device industry, particularly in disease screening for cardiovascular disorders such as cardiac syncope, arrhythmia, and atrial fibrillation. The worldwide restrictions due to the pandemic have led to a surge in demand for remote patient monitoring, making ILRs an essential tool for healthcare resources. According to quarterly financial reports, the product demand for ILRs is expected to grow due to the increasing geriatric population, a high-risk group for chronic cardiac conditions. The NIH and World Health Organization have emphasized the importance of early detection and prevention of cardiovascular diseases, including sudden cardiac deaths. ILRs play a crucial role in identifying cardiac arrhythmias and syncope, enabling timely intervention through cardiac procedures or medication. Moreover, the rising trend of elective procedures, cardiovascular devices, and cardiac assist devices has further boosted the market growth. Physical inactivity, a leading cause of chronic cardiac conditions, has increased the need for ILRs to monitor patients at risk. In conclusion, the Implantable Loop Recorder market is poised for significant growth, driven by disease screening, remote patient monitoring, and the increasing prevalence of cardiovascular disorders.
Market Research Overview
The Implantable Loop Recorder (ILR) market is experiencing significant growth due to the increasing prevalence of cardiovascular diseases (CVDs) and the need for early detection of cardiac abnormalities, particularly in nonstroke and stroke patients. Strict regulations by organizations like the Centers for Medicare and Medicaid Services (CMS) and the Physician Fee Schedule have driven the demand for these devices. ILRs are crucial for atrial fibrillation (AF) detection, a common arrhythmia associated with stroke and sudden cardiac deaths. Companies like Preventice Solutions, Boston Scientific, and RhythMedix are leading the market with their advanced ILRs, featuring ECG analysis, 4G cellular connectivity, and AI-assisted diagnosis. Technological advancements, such as RPM and telemonitoring, have made these devices more accessible, enabling remote monitoring and early intervention. The worldwide restrictions due to the pandemic have further boosted the product demand. Major players in the medical device industry, including Medtronic, Cardiovascular Association, and ASCs, are focusing on reimbursement policies and MIS procedures to expand their market reach. The geriatric population, with a higher risk of CVDs, is a significant target demographic. Cardiac syncope, arrhythmia, and heart failure are some of the chronic cardiac conditions addressed by ILRs. The market is expected to continue growing due to the surging cardiovascular procedures, elective procedures, and the need for cardiac assist devices. The NIH, British Heart Foundation, and World Health Organization are also actively promoting disease screening and lifestyle changes to reduce mortality from CVDs.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
